Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart
- PMID: 26291007
- DOI: 10.1097/JTO.0000000000000663
Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart
Comment on
-
The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification.J Thorac Oncol. 2015 Sep;10(9):1243-1260. doi: 10.1097/JTO.0000000000000630. J Thorac Oncol. 2015. PMID: 26291008
Similar articles
-
The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification.J Thorac Oncol. 2015 Sep;10(9):1243-1260. doi: 10.1097/JTO.0000000000000630. J Thorac Oncol. 2015. PMID: 26291008
-
An Unmet Need in the WHO 2015 Biopsy Classification: Poorly Differentiated NSCCs with Positive Neuroendocrine Markers.J Thorac Oncol. 2016 Feb;11(2):e25-6. doi: 10.1016/j.jtho.2015.10.017. J Thorac Oncol. 2016. PMID: 26811227 No abstract available.
-
Testing for Neuroendocrine Immunohistochemical Markers Should Not Be Performed in Poorly Differentiated NSCCs in the Absence of Neuroendocrine Morphologic Features according to the 2015 WHO Classification.J Thorac Oncol. 2016 Feb;11(2):e26-7. doi: 10.1016/j.jtho.2015.10.018. J Thorac Oncol. 2016. PMID: 26811228 No abstract available.
-
[Pulmonary neuroendocrine tumors in the new WHO 2015 classification: Start of breaking new grounds?].Pathologe. 2015 May;36(3):283-92. doi: 10.1007/s00292-015-0030-2. Pathologe. 2015. PMID: 25956813 Review. German.
-
The 2004 World Health Organization classification of lung tumors.Semin Roentgenol. 2005 Apr;40(2):90-7. doi: 10.1053/j.ro.2005.01.001. Semin Roentgenol. 2005. PMID: 15898407 Review. No abstract available.
Cited by
-
Case report: A golden tail of immunotherapy: significant tail effect in a chemotherapy-resistant advanced pulmonary sarcomatoid carcinoma patient treated by Sintilimab combined with Anlotinib.Front Immunol. 2024 Nov 6;15:1452195. doi: 10.3389/fimmu.2024.1452195. eCollection 2024. Front Immunol. 2024. PMID: 39569200 Free PMC article.
-
Antibiotic Use and Survival in Patients With Late-Stage NSCLC Treated With Chemoimmunotherapy.JTO Clin Res Rep. 2024 Jul 31;5(12):100710. doi: 10.1016/j.jtocrr.2024.100710. eCollection 2024 Dec. JTO Clin Res Rep. 2024. PMID: 39559447 Free PMC article.
-
Investigating the impact of tumor size on survival outcomes in thymoma and thymic carcinoma patients using the SEER database.Sci Rep. 2024 Nov 12;14(1):27680. doi: 10.1038/s41598-024-79186-5. Sci Rep. 2024. PMID: 39533067 Free PMC article.
-
Giant cell carcinoma of the lung with hypertrophic pulmonary osteoarthropathy as a paraneoplastic syndrome: a case report.Gen Thorac Cardiovasc Surg Cases. 2023 Aug 17;2(1):49. doi: 10.1186/s44215-023-00067-w. Gen Thorac Cardiovasc Surg Cases. 2023. PMID: 39516858 Free PMC article.
-
Super-enhancer MYCNOS-SE promotes chemoresistance in small cell lung cancer by recruiting transcription factors CTCF and KLF15.Oncogene. 2024 Nov 8. doi: 10.1038/s41388-024-03202-1. Online ahead of print. Oncogene. 2024. PMID: 39511411
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical